2024 Sep-Oct 01;31(5):e619-e622
Most ASCs and most CMHCs are considered small businesses with total revenues of $16.5 million or less in any single year
Patients with complex medical histories, concurrent medications, or metabolic disorders should undergo thorough evaluation before starting any GLP-1 regimen, regardless of platform
Health care professionals and patients should report adverse events or side effects related to the use of this product to FDA's MedWatch Safety Information and Adverse Event Reporting Program: Complete and submit the report online MedWatch Online Voluntary Reporting Form, or: Download and complete the form, then submit it via fax at 1-800-FDA-0178
These figures reflect reference reconstitution math as reported in research contexts and are provided strictly for research-use-only purposes, not medical guidance
Mistake 3: using the wrong diluent Bacteriostatic water is the correct choice for multi-dose vials